Blog Voices from the Frontlines
A recent national poll has shown support for medical cannabis stands at 89%. The poll was conducted May 24 – 30 by Quinnipiac University, surveying 1,561 registered voters nationwide. This poll closely mirrors the results of a 2014 CNN/ORC national poll, which showed the support level at 88%.
In fact, the support was strong across all ages and party affiliations. While Republicans and older Americans have typically been the least likely to support legal access to medical cannabis therapy, their support levels were show at 81% and 89% respectively. Again, these results nearly replicate the 2014 CNN/ORC poll, in which 84% of Republicans and 84% of voters over age 65 stated their support. Unfortunately, the less than 20% of senior Republicans who oppose medical cannabis are disproportionately represented in Congressional committees.
Last week was a busy one in Sacramento. Hundreds of patients and advocates participated in our California Citizen Lobby Day on Monday. Check out my blog about which medical cannabis bills won and lost by the end of the week.
There is a new action alert this week… Tell your California Senator to vote no on SB 987, which adds an additional 15% tax to medical cannabis statewide.
Get all the news, events, action alerts, & more...
Medical cannabis patients and other stakeholders in California scored victories and suffered defeats in the state legislature today. The Appropriations Committees in the Assembly and Senate decided the fate of hundreds of bills today in their biannual “suspense hearings” – including important bills related to medical cannabis licensing, taxation, and patients’ rights.
The committee votes come just four days after more than one hundred and fifty medical cannabis patients and caregivers gathered in Sacramento to talk face-to-face with lawmakers and staff about medical cannabis bills. Participants in the California Citizen Lobby Day took more than 200 meetings with lawmakers and staff – including members who cast votes in today’s suspense hearings.
Ohio Set to Become 26th Medical Cannabis State, but Employment Language Raises Concerns - Americans for Safe Access
The Ohio Senate passed HB 523 on Wednesday by a vote of 18-15, which would create a retail dispensary medical cannabis program in state.The bill is expected to be signed by Governor John Kasich, which would make Ohio the 26th medical cannabis state in the country.
While the program that will be created under HB 523 is no doubt a step forward for patients in Ohio, the are still major concerns with the program. To give the legislature credit, the senate wisely amended the bill to remove potentially disastrous requirements on physicians and added commission appointments for representatives from the caregivers, nurses, and agriculture. Another reason to celebrate the bill’s passes is that the regulatory process will begin sooner. Given the delays that most state programs have encountered when issuing dispensary and cultivation licenses, the earlier state on regulations will certainly benefit patients. However, there are several areas of the bill that impose unnecessary and harmful burdens upon patients.
US House Approves Amendment to Create Access for Veterans to Medical Cannabis - Americans for Safe Access
Today, the U.S. House of Representatives voted to approve the Veterans Equal Access Amendment (VEAA) to the FY2017 Military Construction and Veterans Affairs (MilConVA) Appropriations bill, which sets the budget for the Veterans Administration (VA). The amendment, which creates a path to medical cannabis therapy for veterans receiving their healthcare through the VA, was approved by a vote of 233-189 with 57 Republicans and 176 Democrats. The amendment was sponsored again by Representative Earl Blumenauer (D-OR) with bipartisan co-sponsorship from Representatives Heck (R-NV), Farr (D-CA), Rohrabacher (R-CA), Reed (R-NY), Titus (D-CA), Lee (D-CA), Gallego (D-AZ), and Polis (D-CA).
Take Action! Tell your Representatives to Protect Veterans & Vote Yes on the Veterans Equal Access Amendment - Americans for Safe Access
Tomorrow, the U.S. House of Representatives will vote on the Veterans Equal Access Amendment as part of the full committee markup of the MilCon-VA Appropriations Bill. The amendment will be Representative Earl Blumenauer (D-OR) and a bipartisan group of cosponsors. It would allow V.A. physicians to make written recommendations to veteran patients in states with medical cannabis programs. Current V.A. policy forbids their physicians from recommending or even discussing the benefits of medical cannabis.
The policy is set by VHA Directive 2011-004. This directive was set to expire on January 31, 2016; however, the policy remains in effect. This means that Congress must take action to fix the problem. The Veterans Equal Access Amendment would help lift this “gag order” that is currently being imposed on VHA physicians. Like the Rohrabacher-Farr Amendment that protect state medical cannabis programs, this amendment would have to be renewed on an annual basis.
There are only 7 days left until the California Citizen Lobby Day. Get registered today so that we can make appointments for you at you Assembly and Senate offices!
Get all the news, events, action alerts, & more...
State Department Confirms Breaking Up NIDA-Monopoly Does Not Violate UN Treaty - Americans for Safe Access
In response to questions from Senator Kirsten Gillibrand’s (D-NY) office, the Bureau of International Narcotics and Law Enforcement at the State Department has gone on record that the U.S. could issue multiple licenses for the cultivation of cannabis for medical and scientific purposes without violating the U.N. Single Convention on Narcotic Drugs. This interpretation is at odds with Drug Enforcement Administration’s (DEA) interpretation that the treaty only allows a single license, which is granted to the National Institute on Drug Abuse (NIDA) creating the “NIDA-monopoly on cannabis,”which has stalled medical cannabis research for years.
According, to NIH:
Under the 1961 international Single Convention on Narcotic Drugs (amended in 1972), cannabis is designated a Schedule I substance, and participating countries are required to restrict production, manufacture, possession and distribution of marijuana except for medical and scientific purposes. The Drug Enforcement Administration (DEA) regulates the cultivation of marijuana for research purposes through licensing requirements and establishing annual aggregate production quotas under the authority of the 1970 Controlled Substances Act (CSA), which implements the Single Convention. To date, the DEA has only issued a single license for the cultivation of marijuana for research, to the University of Mississippi, which is funded through a NIDA contract. Questions on the authority to issue additional licenses would have to be addressed to the DEA.